CHRISTINA MARUYAMA: Open Payments
NPI 1801526363 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 12 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $234 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 1 | $67 |
| ABBVIE INC. | 3 | $67 |
| Novo Nordisk Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: TWIRLA, VRAYLAR, QULIPTA, Ozempic, Sunosi, EVENITY, INSPIRE, BREZTRI.
Industry payments across UT — which companies pay providers there.
